MedPath

SE OF YASHTIMADHU ASCHYOTAN IN THE MANGEMENT OF SIRAJAL (EPISCLERITIS)

Phase 2
Conditions
Health Condition 1: H151- Episcleritis
Registration Number
CTRI/2019/07/020226
Lead Sponsor
Self Vishal Bapu Ratnaparkhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient suffering from Episcleritis.

2.Patients who are ready to accept the treatment will be selected.

Exclusion Criteria

1.Patients having local cause such as foreign body or granuloma.

2.Patients were suffering from Anemia,Gastrointestinal bleeding.

3.Patients taking anticoagulant medication.

4.Patients suffering from Acute stage of infectious eye disease,severe allergic diathesis.

5.Pregnant Women.

6.General and local wound healing,congential anomalies of eye.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To study the efficacy of Yashtimadhu Aschyotan in Sirajal with special reference to episcleritis. <br/ ><br>2.To compare whether the Yashtimadhu Aschyotan is more effective in treatment of Episcleritis.Timepoint: 18 months
Secondary Outcome Measures
NameTimeMethod
1.To study the Sirajal according to Ayurveda and Episcleritis in modern point of view. <br/ ><br>2.To Established Ayurvedic line of Treatment with its modern management of Episcleritis.Timepoint: One and Half year
© Copyright 2025. All Rights Reserved by MedPath